Cargando…
Mapping tumour heterogeneity with pulsed 3D CEST MRI in non-enhancing glioma at 3 T
OBJECTIVE: Amide proton transfer (APT) weighted chemical exchange saturation transfer (CEST) imaging is increasingly used to investigate high-grade, enhancing brain tumours. Non-enhancing glioma is currently less studied, but shows heterogeneous pathophysiology with subtypes having equally poor prog...
Autores principales: | Warnert, Esther A. H., Wood, Tobias C., Incekara, Fatih, Barker, Gareth J., Vincent, Arnaud J. P., Schouten, Joost, Kros, Johan M., van den Bent, Martin, Smits, Marion, Tamames, Juan A. Hernandez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901516/ https://www.ncbi.nlm.nih.gov/pubmed/33606114 http://dx.doi.org/10.1007/s10334-021-00911-6 |
Ejemplares similares
-
3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T
por: Wu, Yulun, et al.
Publicado: (2022) -
Correction to: 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T
por: Wu, Yulun, et al.
Publicado: (2022) -
Microvasculature Features Derived from Hybrid EPI MRI in Non-Enhancing Adult-Type Diffuse Glioma Subtypes
por: Arzanforoosh, Fatemeh, et al.
Publicado: (2023) -
Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners
por: Wu, Yulun, et al.
Publicado: (2023) -
GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas
por: Bender, Benjamin, et al.
Publicado: (2021)